EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Homocysteine, neurodegenerative biomarkers, and APOE ε4 in neurodegenerative diseases

William Z Lin iD, Di Yu, Lisa Y Xiong, Julia Zebarth, Ruoding Wang, Corinne E Fischer, Tarek K Rajji, David F Tang-Wai, Carmela Tartaglia, Gustavo Saposnik, Richard H Swartz, David A Grimes und 21 weitere

Alzheimer's & Dementia · 2025-01 · 21 (1)

DOI: 10.1002/alz.14376 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 19.11.2024. Verfasst von William Z Lin und 32 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Toxicology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Homocysteine, Apolipoprotein E4, Neurodegenerative Diseases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ontario Brain Institute, Baycrest Foundation, Bruyère Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Elevated plasma homocysteine (Hcy) is associated with an increased risk of developing neurodegenerative diseases; however, its relationship with the apolipoprotein E ( APOE ) ε4 allele has not been well characterized. METHODS Participants clinically diagnosed with Alzheimer's disease or mild cognitive impairment (AD/MCI), frontotemporal dementia, Parkinson's disease, or cerebrovascular disease were stratified by the presence of the APOE ε4 allele. Volumetric magnetic resonance imaging, plasma amyloid/tau/neurodegeneration biomarkers, and cognitive performance were quantified. RESULTS Across all diagnostic groups, Hcy was associated with lower brain parenchymal fraction and greater neurofilament light chain in APOE ε4 non‐carriers only. In AD/MCI, Hcy was associated with phosphorylated tau 217 in APOE ε4 non‐carriers, but not in carriers. Exploratory analyses revealed interactions between Hcy and APOE ε4 on memory and visuospatial function. DISCUSSION Hcy may contribute to neurodegeneration depending on the presence of the APOE ε4 allele and specific disease processes. Trials on vitamin B12 supplementation may consider stratifying by APOE genotype. Highlights Homocysteine (Hcy) was associated with neurodegenerative biomarkers across disease groups. Relationships with Hcy were predominantly found in apolipoprotein E ( APOE ) ε4 non‐carriers. In Alzheimer's disease, associations between Hcy and phosphorylated tau 217 were found in APOE ε4 non‐carriers only. Significant interactions existed between Hcy and APOE ε4 status on cognition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HomocysteineApolipoprotein E4Neurodegenerative DiseasesHumansMaleFemaleBiomarkersAgedMagnetic Resonance Imagingtau ProteinsCognitive DysfunctionAlzheimer DiseaseBrainMiddle AgedAged, 80 and overParkinson Disease

Stichwörter der Autor:innen

Alzheimer's diseaseParkinson's diseaseapolipoprotein Ebiomarkerscerebrovascular diseasedementiafrontotemporal dementiahomocysteinemild cognitive impairment

Substanzen

HomocysteineApolipoprotein E4Biomarkerstau Proteins

Autor:innen und Institutionen

  • Department of Pharmacology & Toxicology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
  • KITE Research Institute, Toronto Rehabilitation Institute-University Health Network, Toronto, Ontario, Canada.
  • Neuropsychopharmacology Research Group, Sunnybrook Research Institute, Toronto, Ontario, Canada.
  • Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, Ontario, Canada.

ORCID-Profile: William Z Lin, Walter Swardfager

Förderung

  • Ontario Brain Institute
  • Baycrest Foundation
  • Bruyère Research Institute
  • Centre for Addiction and Mental Health Foundation
  • London Health Sciences Foundation
  • McMaster University Faculty of Health Sciences
  • Ottawa Brain and Mind Research Institute
  • Queen's University Faculty of Health Sciences

Zitieren

APA

Lin, W. Z., Yu, D., Xiong, L. Y., Zebarth, J., Wang, R., Fischer, C. E., Rajji, T. K., Tang-Wai, D. F., Tartaglia, C., Saposnik, G., Swartz, R. H., Grimes, D. A., Lang, A. E., Hegele, R. A., Farhan, S., Ramirez, J., Symons, S., Goubran, M., Binns, M. A., …, & ONDRI Investigators (2025). Homocysteine, neurodegenerative biomarkers, and APOE ε4 in neurodegenerative diseases. Alzheimer's & Dementia, 21(1). https://doi.org/10.1002/alz.14376

Vancouver

Lin WZ, Yu D, Xiong LY, Zebarth J, Wang R, Fischer CE, et al. Homocysteine, neurodegenerative biomarkers, and APOE ε4 in neurodegenerative diseases. Alzheimer's & Dementia. 2025;21(1). doi:10.1002/alz.14376

BibTeX
@article{Lin2025,
  author = {Lin, William Z and Yu, Di and Xiong, Lisa Y and Zebarth, Julia and Wang, Ruoding and Fischer, Corinne E and Rajji, Tarek K and Tang-Wai, David F and Tartaglia, Carmela and Saposnik, Gustavo and Swartz, Richard H and Grimes, David A and Lang, Anthony E and Hegele, Robert A and Farhan, Sali and Ramirez, Joel and Symons, Sean and Goubran, Maged and Binns, Malcolm A and Lou, Wendy and Dixon, Roger A and Orange, Joseph B and Roberts, Angela C and Troyer, Angela K and Zetterberg, Henrik and Herrmann, Nathan and Rabin, Jennifer S and MacIntosh, Bradley J and Masellis, Mario and Lanctôt, Krista L and Black, Sandra E and Swardfager, Walter and ONDRI Investigators, ONDRI Investigators},
  title = {Homocysteine, neurodegenerative biomarkers, and APOE ε4 in neurodegenerative diseases},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {1},
  doi = {10.1002/alz.14376}
}
Kostenlos starten →